10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2018 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 12, 2019) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Revenues: | |||
| Premiums | $ 178,087 | 158,453 | 144,118 |
| Products | 29,601 | 26,366 | 26,658 |
| Services | 17,183 | 15,317 | 13,236 |
| Investment and other income | 1,376 | 1,023 | 828 |
| Total revenues | 226,247 | 201,159 | 184,840 |
| Operating costs: | |||
| Medical costs | 145,403 | 130,036 | 117,038 |
| Operating costs | 34,074 | 29,557 | 28,401 |
| Cost of products sold | 26,998 | 24,112 | 24,416 |
| Depreciation and amortization | 2,428 | 2,245 | 2,055 |
| Total operating costs | 208,903 | 185,950 | 171,910 |
| Earnings from operations | 17,344 | 15,209 | 12,930 |
| Interest expense | (1,400) | (1,186) | (1,067) |
| Earnings before income taxes | 15,944 | 14,023 | 11,863 |
| Provision for income taxes | (3,562) | (3,200) | (4,790) |
| Net earnings | 12,382 | 10,823 | 7,073 |
| Earnings attributable to noncontrolling interests | (396) | (265) | (56) |
| Net earnings attributable to UnitedHealth Group common shareholders | 11,986 | 10,558 | 7,017 |
| Earnings per share attributable to UnitedHealth Group common shareholders: | |||
| Basic | 12.45 | 10.95 | 7.37 |
| Diluted | 12.19 | 10.72 | 7.25 |
| Basic weighted-average number of common shares outstanding | 963 | 964 | 952 |
| Dilutive effect of common share equivalents | 20 | 21 | 16 |
| Diluted weighted-average number of common shares outstanding | 983 | 985 | 968 |
| Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents | 6 | 5 | 3 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2018 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 12, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Net earnings | $ 12,382 | 10,823 | 7,073 |
| Other comprehensive (loss) income: | |||
| Gross unrealized (losses) gains on investment securities during the period | (294) | 209 | (73) |
| Income tax effect | 67 | (72) | 26 |
| Total unrealized (losses) gains, net of tax | (227) | 137 | (47) |
| Gross reclassification adjustment for net realized gains included in net earnings | (62) | (83) | (166) |
| Income tax effect | 14 | 30 | 60 |
| Total reclassification adjustment, net of tax | (48) | (53) | (106) |
| Total foreign currency translation (losses) gains | (1,242) | (70) | 806 |
| Other comprehensive (loss) income | (1,517) | 14 | 653 |
| Comprehensive income | 10,865 | 10,837 | 7,726 |
| Comprehensive income attributable to noncontrolling interests | (396) | (265) | (56) |
| Comprehensive income attributable to UnitedHealth Group common shareholders | 10,469 | 10,572 | 7,670 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2018 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 12, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Operating activities | |||
| Net earnings | $ 12,382 | 10,823 | 7,073 |
| Noncash items: | |||
| Depreciation and amortization | 2,428 | 2,245 | 2,055 |
| Deferred income taxes | 42 | (965) | 81 |
| Share-based compensation | 638 | 597 | 485 |
| Other, net | (71) | 217 | (82) |
| Net change in other operating items, net of effects from acquisitions and changes in AARP balances: | |||
| Accounts receivable | (1,351) | (1,062) | (1,357) |
| Other assets | (750) | (630) | (1,601) |
| Medical costs payable | 1,831 | 1,284 | 1,849 |
| Accounts payable and other liabilities | 526 | 930 | 1,494 |
| Unearned revenues | 38 | 157 | (202) |
| Cash flows from operating activities | 15,713 | 13,596 | 9,795 |
| Investing activities | |||
| Purchases of investments | (14,010) | (14,588) | (17,547) |
| Sales of investments | 3,641 | 4,623 | 7,339 |
| Maturities of investments | 6,270 | 5,646 | 4,281 |
| Cash paid for acquisitions, net of cash assumed | (5,997) | (2,131) | (1,760) |
| Purchases of property, equipment and capitalized software | (2,063) | (2,023) | (1,705) |
| Other, net | (226) | (126) | 37 |
| Cash flows used for investing activities | (12,385) | (8,599) | (9,355) |
| Financing activities | |||
| Common share repurchases | (4,500) | (1,500) | (1,280) |
| Cash dividends paid | (3,320) | (2,773) | (2,261) |
| Proceeds from common stock issuances | 838 | 688 | 429 |
| Repayments of long-term debt | (2,600) | (4,398) | (2,596) |
| Repayments of commercial paper, net | (201) | (3,508) | (382) |
| Proceeds from issuance of long-term debt | 6,935 | 5,291 | 3,968 |
| Customer funds administered | (131) | 3,172 | 1,692 |
| Other, net | (1,386) | (413) | (581) |
| Cash flows used for financing activities | (4,365) | (3,441) | (1,011) |
| Effect of exchange rate changes on cash and cash equivalents | (78) | (5) | 78 |
| (Decrease) increase in cash and cash equivalents | (1,115) | 1,551 | (493) |
| Cash and cash equivalents, beginning of period | 11,981 | 10,430 | |
| Cash and cash equivalents, end of period | 10,866 | 11,981 | 10,430 |
| Supplemental cash flow disclosures | |||
| Cash paid for interest | 1,410 | 1,133 | 1,055 |
| Cash paid for income taxes | 3,257 | 4,004 | 4,726 |
| Supplemental schedule of non-cash investing activities | |||
| Common stock issued for acquisitions | 0 | 2,164 | 0 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
UNITEDHEALTH GROUP INC | ||
Ticker: UNH Fiscal Year: 2018 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2018 10-K (Filed: Feb 12, 2019) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2018 | Dec 31, 2017 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 10,866 | 11,981 |
| Short-term investments | 3,458 | 3,509 |
| Accounts receivable, net of allowances of $712 and $641 | 11,388 | 9,568 |
| Other current receivables, net of allowances of $502 and $440 | 6,862 | 6,262 |
| Assets under management | 3,032 | 3,101 |
| Prepaid expenses and other current assets | 3,086 | 2,663 |
| Total current assets | 38,692 | 37,084 |
| Long-term investments | 32,510 | 28,341 |
| Property, equipment and capitalized software, net of accumulated depreciation and amortization of $4,141 and $3,694 | 8,458 | 7,013 |
| Goodwill | 58,910 | 54,556 |
| Other intangible assets, net of accumulated amortization of $4,592 and $4,309 | 9,325 | 8,489 |
| Other assets | 4,326 | 3,575 |
| Total assets | 152,221 | 139,058 |
| Liabilities, redeemable noncontrolling interests and equity | ||
| Current liabilities: | ||
| Medical costs payable | 19,891 | 17,871 |
| Accounts payable and accrued liabilities | 16,705 | 15,180 |
| Commercial paper and current maturities of long-term debt | 1,973 | 2,857 |
| Unearned revenues | 2,396 | 2,269 |
| Other current liabilities | 12,244 | 12,286 |
| Total current liabilities | 53,209 | 50,463 |
| Long-term debt, less current maturities | 34,581 | 28,835 |
| Deferred income taxes | 2,474 | 2,182 |
| Other liabilities | 5,730 | 5,556 |
| Total liabilities | 95,994 | 87,036 |
| Commitments and contingencies (Note 12) | ||
| Redeemable noncontrolling interests | 1,908 | 2,189 |
| Equity: | ||
| Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding | 0 | 0 |
| Common stock, $0.01 par value - 3,000 shares authorized; 960 and 969 issued and outstanding | 10 | 10 |
| Additional paid-in capital | 0 | 1,703 |
| Retained earnings | 55,846 | 48,730 |
| Accumulated other comprehensive loss | (4,160) | (2,667) |
| Nonredeemable noncontrolling interests | 2,623 | 2,057 |
| Total equity | 54,319 | 49,833 |
| Total liabilities, redeemable noncontrolling interests and equity | 152,221 | 139,058 |
| External Links | |
| UNITEDHEALTH GROUP INC (UNH) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |